You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Relapse ALL

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapsed B-cell Acute Lymphoblastic Leukemia, Childhood, Refractory B-cell Acute Lymphoblastic Leukemia, Childhood,

Recruiting
  • Relapsed B-cell Acute Lymphoblastic Leukemia, Childhood
  • +2 more
  • CAR-T19/CAR-T22
  • Changsha, Hunan, China
    Xiangya Hospital Central South University
Feb 3, 2021

Acute Lymphoblastic Leukemia (ALL) Trial in Worldwide (Marqibo® (vincristine sulfate liposomes injection))

Completed
Has Results
  • Acute Lymphoblastic Leukemia (ALL)
  • Marqibo® (vincristine sulfate liposomes injection)
  • Los Angeles, California
  • +32 more
Feb 8, 2021

MDS, Leukemia, Myeloid, Acute Trial in London (DLI will be administered to all patients at Month 4 (+/- 20 days) after stem cell

Unknown status
  • Myelodysplastic Syndromes
  • Leukemia, Myeloid, Acute
  • DLI will be administered to all patients at Month 4 (+/- 20 days) after stem cell transplant regardless of peripheral blood CD3 chimerism (including if they have full donor chimerism)
  • DLI will be administered from Month 6 (+/- 20 days) after stem cell transplant according to institutional practice
  • London, United Kingdom
    King's College Hospital NHS Foundation Trust
Apr 1, 2020

Acute Promyelocytic Leukemia, Induction Therapy, Oral Trial in Beijing (Etoposide, Daunorubicin)

Recruiting
  • Acute Promyelocytic Leukemia
  • +2 more
  • Beijing, Beijing, China
    Peking University Institute of Hematology
Apr 26, 2023

Relapsed T-Cell Acute Lymphoblastic Leukemia, Relapsed T-Cell Lymphoblastic Lymphoma Trial in Worldwide (Nelarabine, Etoposide,

Terminated
Has Results
  • Relapsed T-Cell Acute Lymphoblastic Leukemia
  • Relapsed T-Cell Lymphoblastic Lymphoma
  • Los Angeles, California
  • +36 more
Sep 8, 2020

The Relapses in Childhood Acute Lymphoplastic Leukemia Excluding

Completed
  • Leukemia, Acute
    • (no location specified)
    Jul 23, 2023

    Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia Trial in Worldwide (radiation, biological, drug)

    Suspended
    • Down Syndrome
    • Recurrent B Acute Lymphoblastic Leukemia
    • 3-Dimensional Conformal Radiation Therapy
    • +13 more
    • Birmingham, Alabama
    • +202 more
    Jan 17, 2023

    Prophylactic HQP1351 Therapy, Third Generation TKI Trial in Guanzhou (HQP1351( Olverembatinib dimesylate))

    Withdrawn
    • Prophylactic HQP1351 Therapy
    • Third Generation TKI
    • HQP1351( Olverembatinib dimesylate)
    • Guanzhou, China
      Department of Hematology, Nanfang Hospital, Southern Medical Uni
    Jan 16, 2023

    Schizophrenia Relapse, Light Pollution Trial in Hefei (light cover)

    Completed
    • Schizophrenia Relapse
    • Light Pollution
    • light cover
    • Hefei, Anhui, China
      Weizhuo Yi
    Aug 1, 2023

    Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML) Trial in Seoul

    Active, not recruiting
    • Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML)
    • Seoul, Korea, Republic of
      Asan Medical Center, University of Ulsan College of Medicine
    Oct 19, 2023

    Elevated Factor VIII Related Labs asBiomarker for Incomplete

    Not yet recruiting
    • Multiple Sclerosis, Relapsing-Remitting
    • blood tests drawn days 1, 8, 22 and 90 of the study
    • (no location specified)
    Jun 22, 2023

    Graft Vs Host Disease Trial in Vandoeuvre Les Nancy (Uvadex, Steroids)

    Not yet recruiting
    • Graft Vs Host Disease
    • Vandoeuvre Les Nancy, France
      CHRU de Nancy
    Nov 10, 2023

    Clinical Prognostic Score to Predict Relapse in VL

    Not yet recruiting
    • Visceral Leishmaniasis
    • No intervention
    • (no location specified)
    Nov 3, 2022

    Intensive Conditioning With Thiotepa Combined With Bu/Flu/Ara-C

    Not yet recruiting
    • Acute Myeloid Leukemia
    • +4 more
      • (no location specified)
      Nov 1, 2023

      Non Small Cell Lung Cancer, EGFR Activating Mutation, EGFR DEL19 Trial in France (Plasma ctDNA, FFPE blocks)

      Not yet recruiting
      • Non Small Cell Lung Cancer
      • +3 more
      • Plasma ctDNA
      • FFPE blocks
      • Angers, France
      • +35 more
      Sep 19, 2023

      Cytarabine+Thiotepa + Fludarabine + Busulfan, T Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma Trial in Hangzhou

      Recruiting
      • Cytarabine+Thiotepa + Fludarabine + Busulfan
      • T Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
      • cytarabine+thiotepa+ fludarabine + busulfan
      • Hangzhou, China
        The First Affiliated Hospital, College of Medicine, Zhejiang Uni
      Oct 26, 2022

      B-All, Acute Lymphoblastic Leukemia Trial run by the National Cancer Institute (NCI) (NGS testing)

      Not yet recruiting
      • B-All
      • Acute Lymphoblastic Leukemia
      • NGS testing
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Feb 2, 2023

      Identify Resected Non-small-cell Lung Cancer With High Risk of

      Recruiting
      • Non-small Cell Lung Cancer Stage IIIA
      • Resected non small cell lung cancer
      • Toulouse, France
        Julien MAZIERES
      Feb 8, 2023

      Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia Trial in Tianjin (Vincristine, Daunorubicin, Cyclophosphamide)

      Recruiting
      • Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia
      • Tianjin, China
        Institute of Hematology & Blood Diseases Hospital
      Dec 13, 2022

      Acute Myeloid Leukemia At Initial Diagnosis and/or Relapse in

      Not yet recruiting
      • Acute Myeloid Leukemia
      • Genetic Predisposition to Disease
      • Collection of blood sample of bone marrow (cohort 1)
      • Collection of blood sample of bone marrow (cohort 2 and 3)
      • (no location specified)
      Mar 6, 2023

      Substance Use Disorders Trial in Alexandria (Mindfulness-Based Relapse Prevention program)

      Recruiting
      • Substance Use Disorders
      • Mindfulness-Based Relapse Prevention program
      • Alexandria, Egypt
        Faculty of Nursing
      Aug 11, 2023

      Blood Pressure, Dyslipidemias, Dysglycemia Trial (Snus with or without tobacco)

      Not yet recruiting
      • Blood Pressure
      • +3 more
      • Snus with or without tobacco
      • (no location specified)
      Sep 2, 2023

      Acute Myeloid Leukemia, MDS Trial in China (Fludarabine, busulfan and melphalan, Fludarabine and Busulfan)

      Active, not recruiting
      • Acute Myeloid Leukemia
      • Myelodysplastic Syndromes
      • Fludarabine, busulfan and melphalan
      • Fludarabine and Busulfan
      • Fuzhou, Fujian, China
      • +8 more
      Aug 14, 2023

      Dose Dense Chemotherapy in Elderly Patients > 80 Years Old With

      Completed
      • DLBCL
      • Old Age; Debility
        • Homburg, Saarland, Germany
          Saarland University Medical Center
        Nov 20, 2023

        Hematopoietic Malignancy, Relapse/Recurrence, Hematopoietic Stem Cell Transplantation Trial in Suzhou (Umbilical Cord Blood

        Recruiting
        • Hematopoietic Malignancy
        • +2 more
        • Umbilical Cord Blood Transplantation
        • Suzhou, Jiangsu, China
          The First Affiliated Hospital of Soochow university
        Nov 6, 2023